James A. Bianco, President and CEO at CTI BIOPHARMA CORP (CTIC), sold 110,000 shares at $1.29 ($139K) on 2015-12-28, disclosed to the SEC on 2015-12-30.
Scheduled sale ($139k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.29 | 10,000 | $13K | 9.3% |
| 2 | $1.26 | 100,000 | $126K | 90.7% |
| Total | $1.26 avg | 110,000 | $139K | 100% |
| Filing → |
| CTIC | SELL | 2016-04-29 | $5K | — | Filing → |
| CTIC | SELL | 2016-03-30 | $5K | — | Filing → |
| CTIC | SELL | 2016-03-23 | $350K | — | Filing → |